SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-011993
Filing Date
2022-05-12
Accepted
2022-05-12 07:11:31
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arav20220331_10q.htm   iXBRL 10-Q 828208
2 EXHIBIT 31.1 ex_344030.htm EX-31.1 12023
3 EXHIBIT 31.2 ex_344031.htm EX-31.2 12079
4 EXHIBIT 32.1 ex_344032.htm EX-32.1 5433
5 EXHIBIT 32.2 ex_344033.htm EX-32.2 5459
  Complete submission text file 0001437749-22-011993.txt   4434776

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20220331.xsd EX-101.SCH 43971
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20220331_cal.xml EX-101.CAL 26746
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220331_def.xml EX-101.DEF 311321
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220331_lab.xml EX-101.LAB 272849
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220331_pre.xml EX-101.PRE 333189
54 EXTRACTED XBRL INSTANCE DOCUMENT arav20220331_10q_htm.xml XML 592491
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 22915682
SIC: 2834 Pharmaceutical Preparations